Log in
Enquire now
‌

US Patent 7766012 Device for the controlled inhalation of therapeutic aerosols

Patent 7766012 was granted and assigned to Activaero on August, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Current Assignee
‌
Activaero
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7766012
Date of Patent
August 3, 2010
Patent Application Number
09810988
Date Filed
March 16, 2001
Patent Citations Received
‌
US Patent 11938265 Devices, systems, and methods for adherence monitoring and patient interaction
0
‌
US Patent 11804303 Evaluation of respiratory disease risk in a geographic region based on medicament device monitoring
Patent Primary Examiner
‌
Justine R. Yu
Patent abstract

A device for the controlled inhalation of therapeutic aerosols comprises means providing individual patient parameters and/or aerosol parameters for the inhalation. The aerosol doses, such as the tidal volume and the respiratory flow, are individually adjusted on the basis of these individual parameters. Thus, the inhalation device may be individually adjusted to the patient to be treated.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7766012 Device for the controlled inhalation of therapeutic aerosols

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.